Development and validation of enzyme-linked immunosorbent assays for the measurement of infliximab and anti-drug antibody levels

Infliximab and its anti-drug antibody (ADA) serum concentrations exhibit a strong correlation with clinical response and loss of response. The use of therapeutic drug monitoring to measure the concentration of infliximab and ADA can facilitate clinical decision-making, helping patients attain optima...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiang, Dong, Li, Ninghong, Liu, Lu, Yu, Hengyi, Li, Xiping, Zhao, Tinghui, Liu, Dong, Gong, Xuepeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682623/
https://www.ncbi.nlm.nih.gov/pubmed/38034789
http://dx.doi.org/10.1016/j.heliyon.2023.e21858

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682623/
https://www.ncbi.nlm.nih.gov/pubmed/38034789
http://dx.doi.org/10.1016/j.heliyon.2023.e21858

Ejemplares similares